Tech Company Financing Transactions

MyoScience Funding Round

On 9/13/2013, MyoScience secured $25 million in Series E funding from Accuitive Medical Ventures, American Equities Overseas and De Novo Ventures.

Transaction Overview

Company Name
Announced On
9/13/2013
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series E
Investors

Accuitive Medical Ventures (Thomas Weldon)

American Equities Overseas

De Novo Ventures (Richard Ferrari)

Medicis Capital

Saratoga Ventures

Valiance Asset Management

Proceeds Purpose
The company will use the funding proceeds for expanding its geography and indications to recognize the full potential of their platform technology.

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
46400 Fremont Blvd.
Fremont, CA 94538
USA
Email Address
Overview
MyoScience is developing an innovative, hand held medical device designed to be used for facial rejuvenation. It is currently being evaluated in clinical studies for the treatment of facial wrinkles like frown lines between the brow, forehead lines, and crow's feet.
Profile
MyoScience LinkedIn Company Profile
Social Media
MyoScience Company Twitter Account
Company News
MyoScience News
Facebook
MyoScience on Facebook
YouTube
MyoScience on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Timothy Still
  Timothy Still LinkedIn Profile  Timothy Still Twitter Account  Timothy Still News  Timothy Still on Facebook
Executive Vice President
David Derminio
  David Derminio LinkedIn Profile  David Derminio Twitter Account  David Derminio News  David Derminio on Facebook
VP - Finance
Andrew Jones
  Andrew Jones LinkedIn Profile  Andrew Jones Twitter Account  Andrew Jones News  Andrew Jones on Facebook
VP - Human Resources
Patti Camarena
  Patti Camarena LinkedIn Profile  Patti Camarena Twitter Account  Patti Camarena News  Patti Camarena on Facebook
VP - Marketing
Kris Kumar
  Kris Kumar LinkedIn Profile  Kris Kumar Twitter Account  Kris Kumar News  Kris Kumar on Facebook
VP - Operations
Greg Takaki
  Greg Takaki LinkedIn Profile  Greg Takaki Twitter Account  Greg Takaki News  Greg Takaki on Facebook
VP - R & D
Eric Johanson
  Eric Johanson LinkedIn Profile  Eric Johanson Twitter Account  Eric Johanson News  Eric Johanson on Facebook
VP - Regulatory Affairs
Kent Jones
  Kent Jones LinkedIn Profile  Kent Jones Twitter Account  Kent Jones News  Kent Jones on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/13/2013: Crown Bioscience venture capital transaction
Next: 9/13/2013: Insightly venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary